Table of Contents
Chromatography Research International
Volume 2011, Article ID 815183, 7 pages
http://dx.doi.org/10.4061/2011/815183
Research Article

Determination of Glucosamine in Human Plasma by High-Performance Liquid Chromatography-Atmospheric Pressure Chemical Ionization Source-Tandem Mass Spectrometry

1School of Pharmaceutical Sciences, Central South University, 410013 Changsha, China
2Bioanalytical Laboratory, Hunan Tiger-Xiangya R.&D. Company Ltd., 410013 Changsha, China

Received 22 March 2011; Revised 13 April 2011; Accepted 13 April 2011

Academic Editor: Irene Panderi

Copyright © 2011 Xingchen Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Pashkova, A. Pirogov, A. Bendryshev, E. Ivanaynen, and O. Shpigun, “Determination of underivatized glucosamine in human plasma by high-performance liquid chromatography with electrochemical detection: application to pharmacokinetic study,” Journal of Pharmaceutical and Biomedical Analysis, vol. 50, no. 4, pp. 671–674, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. P. S. Chan, J. P. Caron, G. J. M. Rosa, and M. W. Orth, “Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E2 in articular cartilage explants,” Osteoarthritis and Cartilage, vol. 13, no. 5, pp. 387–394, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. N. Gouze, A. Bianchi, P. Bécuwe et al., “Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-κB pathway,” FEBS Letters, vol. 510, no. 3, pp. 166–170, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Block, T. R. Oegema, J. D. Sandy, and A. Plaas, “The effects of oral glucosamine on joint health: is a change in research approach needed?” Osteoarthritis and Cartilage, vol. 18, no. 1, pp. 5–11, 2010. View at Publisher · View at Google Scholar
  5. R. Largo, M. A. Alvarez-Soria, I. Díez-Ortego et al., “Glucosamine inhibits IL-1β-induced NF-κB activation in human osteoarthritic chondrocytes,” Osteoarthritis and Cartilage, vol. 11, no. 4, pp. 290–298, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Hong, Y.-K. Park, M. Choi et al., “Differential down-regulation of COX-2 and MMP-13 in human skin fibroblasts by glucosamine-hydrochloride,” Journal of Dermatological Science, vol. 56, no. 1, pp. 43–50, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Richy, O. Bruyere, O. Ethgen, M. Cucherat, Y. Henrotin, and J. Y. Reginster, “Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis,” Archives of Internal Medicine, vol. 163, no. 13, pp. 1514–1522, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Wangroongsub, A. Tanavalee, V. Wilairatana, and S. Ngarmukos, “Comparable clinical outcomes between glucosamine sulfate-potassium chloride and glucosamine sulfate sodium chloride in patients with mild and moderate knee osteoarthritis: a randomized, double-blind study,” Journal of the Medical Association of Thailand, vol. 93, no. 7, pp. 805–811, 2010. View at Google Scholar
  9. M. Piperno, P. Reboul, M. P. Hellio Le Graverand et al., “Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro,” Osteoarthritis and Cartilage, vol. 8, no. 3, pp. 207–212, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Persiani, R. Rotini, G. Trisolino et al., “Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose,” Osteoarthritis and Cartilage, vol. 15, no. 7, pp. 764–772, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Y. Reginster, R. Deroisy, L. C. Rovati et al., “Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial,” Lancet, vol. 357, no. 9252, pp. 251–256, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. T. E. Towheed, T. P. Anastassiades, B. Shea, J. Houpt, V. Welch, and M. C. Hochberg, “Glucosamine therapy for treating osteoarthritis,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD002946, 2005. View at Google Scholar · View at Scopus
  13. I. Setnikar and L. C. Rovati, “Absorption, distribution, metabolism and excretion of glucosamine sulfate: a review,” Arzneimittel-Forschung, vol. 51, no. 9, pp. 699–725, 2001. View at Google Scholar · View at Scopus
  14. T. S. Barclay, C. Tsourounis, and G. M. McCart, “Glucosamine,” Annals of Pharmacotherapy, vol. 32, no. 5, pp. 574–579, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. J. W. Anderson, R. J. Nicolosi, and J. F. Borzelleca, “Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy,” Food and Chemical Toxicology, vol. 43, no. 2, pp. 187–201, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Pouwels, J. R. Jacobs, P. N. Span, J. A. Lutterman, P. Smits, and C. J. Tack, “Short-term glucosamine infusion does not affect insulin sensitivity in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 5, pp. 2099–2103, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Monauni, M. G. Zenti, A. Cretti et al., “Effects of glucosamine infusion on insulin secretion and insulin action in humans,” Diabetes, vol. 49, no. 6, pp. 926–935, 2000. View at Google Scholar · View at Scopus
  18. S. Persiani, E. Roda, L. C. Rovati, M. Locatelli, G. Giacovelli, and A. Roda, “Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man,” Osteoarthritis and Cartilage, vol. 13, no. 12, pp. 1041–1049, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. B. W. Echard, N. A. Talpur, K. A. Funk, D. Bagchi, and H. G. Preuss, “Effects of oral glucosamine and chondroitin sulfate alone and in combination on the metabolism of SHR and SD rats,” Molecular and Cellular Biochemistry, vol. 225, no. 1-2, pp. 85–91, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. L.-J. Zhang, T.-M. Huang, X.-L. Fang et al., “Determination of glucosamine sulfate in human plasma by precolumn derivatization using high performance liquid chromatography with fluorescence detection: its application to a bioequivalence study,” Journal of Chromatography B, vol. 842, no. 1, pp. 8–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Zhong, D. Zhong, and X. Chen, “Improved and simplified liquid chromatography/electrospray ionization mass spectrometry method for the analysis of underivatized glucosamine in human plasma,” Journal of Chromatography B, vol. 854, no. 1-2, pp. 291–298, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Roda, L. Sabatini, A. Barbieri et al., “Development and validation of a sensitive HPLC-ESI-MS/MS method for the direct determination of glucosamine in human plasma,” Journal of Chromatography B, vol. 844, no. 1, pp. 119–126, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. T.-M. Huang, L. Cai, B. Yang, M.-X. Zhou, Y.-F. Shen, and G.-L. Duan, “Liquid chromatography with electrospray ionization mass spectrometry method for the assay of glucosamine sulfate in human plasma: validation and application to a pharmacokinetic study,” Biomedical Chromatography, vol. 20, no. 3, pp. 251–256, 2006. View at Publisher · View at Google Scholar